May 5, 2015 Clinical Research/Diagn. M&A, Partnerships

Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

MENLO PARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone under its development, commercialization and license agreement with F. Hoffman-La Roche Ltd (Roche), earning an additional $10 million.The development, commercialization and license... Read more

May 5, 2015 Licensing, IP, and Legal M&A, Partnerships Microscopy

Pacific Biosciences and RainDance Technologies Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly

MENLO PARK, Calif. and BILLERICA, Mass., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, and RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, today announced their entry into a co-development and co-marketing agreement to commercialize... Read more

May 4, 2015 Life Science Tools

BGI Adopts Single Molecule, Real-Time Sequencing from Pacific Biosciences

MENLO PARK, Calif., May 4, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that BGI, the world’s largest genomics organization, has purchased its first PacBio RS II instrument and plans to purchase additional units in order to integrate Single Molecule, Real-Time (SMRT®) Sequencing... Read more

April 27, 2015 Licensing, IP, and Legal Life Science Tools Liq. Handling & Robotics Product Launch

Pacific Biosciences Introduces New Solutions for Comprehensive and Efficient Targeted Sequencing and Multiplexing of Samples

MENLO PARK, Calif., April 27, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced the introduction of several new solutions for targeted sequencing applications.The company has introduced a new workflow that combines Roche NimbleGen’s SeqCap EZ enrichment technology with large DNA fragments (up to... Read more